Prevalence of chronic obstructive pulmonary disease in asymptomatic smokers.

作者: Raúl Sansores , Alejandra Ramírez-Venegas , Oliver Pérez-Bautista , Ramcés Falfan-Valencia , Jaime Villalba-Caloca

DOI: 10.2147/COPD.S91742

关键词: Asymptomatic DiseasesObstructive lung diseasePhysical therapyLungMedicineInternal medicineSpirometryAsymptomaticCOPDMultivariate analysisSmoking cessation

摘要: BACKGROUND Physicians do not routinely recommend smokers to undergo spirometry unless they are symptomatic. OBJECTIVE To test the hypothesis that there a significant number of asymptomatic with chronic obstructive pulmonary disease (COPD), we estimated prevalence COPD in group smokers. METHODS Two thousand nine hundred and sixty-one cumulative consumption history at least 10 pack-years, either symptoms or without (WOS) were invited perform complete symptom questionnaire. RESULTS Six thirty-seven (21.5%) had no symptoms, whereas 2,324 (78.5%) one symptom. The subjects WOS was 1.5% when considering whole (45/2,961) 7% only (45/637). From 329 COPD, 13.7% WOS. Subjects younger, better lung function lower cigarettes, as both cigarettes per day pack-years. According severity airflow limitation, 69% vs 87% classified Global Initiative for Chronic Obstructive Lung Disease stages I-II groups, respectively (P<0.001). A multivariate analysis showed forced expiratory volume 1 second (mL) predictive factor CONCLUSION Prevalence is 1.5%. This may be excluded from benefit an "early" intervention, just pharmacological but also smoking cessation counseling. higher contribute prevent early diagnosis.

参考文章(33)
Karen Duvall, Gerard W. Frank, Identifying Chronic Obstructive Pulmonary Disease in Primary Care of Urban Underserved Patients: Tools, Applications, and Challenges Journal of the National Medical Association. ,vol. 102, pp. 570- 578 ,(2010) , 10.1016/S0027-9684(15)30623-4
Bartolomé R. Celli, Nicola E. Thomas, Julie A. Anderson, Gary T. Ferguson, Christine R. Jenkins, Paul W. Jones, Jørgen Vestbo, Katharine Knobil, Julie C. Yates, Peter M. A. Calverley, Effect of Pharmacotherapy on Rate of Decline of Lung Function in Chronic Obstructive Pulmonary Disease Results from the TORCH Study American Journal of Respiratory and Critical Care Medicine. ,vol. 178, pp. 332- 338 ,(2008) , 10.1164/RCCM.200712-1869OC
Jadwiga A. Wedzicha, Peter M. A. Calverley, Terence A. Seemungal, Gerry Hagan, Zainab Ansari, Robert A. Stockley, The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide. American Journal of Respiratory and Critical Care Medicine. ,vol. 177, pp. 19- 26 ,(2008) , 10.1164/RCCM.200707-973OC
John R. Hurst, Jørgen Vestbo, Antonio Anzueto, Nicholas Locantore, Hana Müllerova, Ruth Tal-Singer, Bruce Miller, David A. Lomas, Alvar Agusti, William MacNee, Peter Calverley, Stephen Rennard, Emiel F.M. Wouters, Jadwiga A. Wedzicha, Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease The New England Journal of Medicine. ,vol. 363, pp. 1128- 1138 ,(2010) , 10.1056/NEJMOA0909883
Marc Miravitlles, Cristian de la Roza, Karlos Naberan, Maite Lamban, Elena Gobartt, Antonio Martin, Use of spirometry and patterns of prescribing in COPD in primary care Respiratory Medicine. ,vol. 101, pp. 1753- 1760 ,(2007) , 10.1016/J.RMED.2007.02.019
Francesco Blasi, Giancarlo Cesana, Sara Conti, Virginio Chiodini, Stefano Aliberti, Carla Fornari, Lorenzo Giovanni Mantovani, The Clinical and Economic Impact of Exacerbations of Chronic Obstructive Pulmonary Disease: A Cohort of Hospitalized Patients PLoS ONE. ,vol. 9, pp. e101228- ,(2014) , 10.1371/JOURNAL.PONE.0101228
Marc Decramer, Bartolome Celli, Steven Kesten, Theodore Lystig, Sunil Mehra, Donald P Tashkin, Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial The Lancet. ,vol. 374, pp. 1171- 1178 ,(2009) , 10.1016/S0140-6736(09)61298-8
David Price, Daryl Freeman, Jen Cleland, Alan Kaplan, Frank Cerasoli, Earlier diagnosis and earlier treatment of COPD in primary care. Primary Care Respiratory Journal. ,vol. 20, pp. 15- 22 ,(2010) , 10.4104/PCRJ.2010.00060
Marc Miravitlles, Cristian de la Roza, Josep Morera, Teodoro Montemayor, Elena Gobartt, Antonio Martín, José Luis Alvarez-Sala, Chronic respiratory symptoms, spirometry and knowledge of COPD among general population. Respiratory Medicine. ,vol. 100, pp. 1973- 1980 ,(2006) , 10.1016/J.RMED.2006.02.024